ALLMedicine™ Lipid Disorders Center
Research & Reviews 517 results
https://doi.org/10.4158/CS-2020-0490
Endocrine Practice : Official Journal of the American Col... Handelsman Y, Jellinger PS et. al.
Jan 20th, 2021 - The treatment of lipid disorders begins with lifestyle therapy to improve nutrition, physical activity, weight, and other factors that affect lipids. Secondary causes of lipid disorders should be addressed, and pharmacologic therapy initiated base...
https://doi.org/10.1007/s11255-020-02731-4 10.3390/ijms20112850 10.1055/s-0042-110231 10.1016/S0140-6736(18)32279-7 10.1111/dom.14007 10.1111/jdi.12255 10.1007/s00592-015-0753-9 10.1152/ajprenal.00404.2009 10.1194/jlr.P040501 10.1016/j.ejphar.2012.02.027 10.1016/j.bbrc.2003.11.115 10.1210/en.2010-1059 10.3390/nu8010030 10.1074/jbc.M605798200 10.3168/jds.2015-9736 10.1158/0008-5472.CAN-13-0382-T 10.1002/kjm2.12226 10.1111/j.2040-1124.2011.00131.x 10.2147/IJNRD.S37893 10.5527/wjn.v3.i3.64 10.1016/j.biopha.2009.08.002 10.12659/MSM.917128 10.12659/MSM.915038 10.1016/j.intimp.2013.01.024 10.1016/0092-8674(94)90234-8 10.1002/jcb.28786 10.1155/2013/592576 10.1074/jbc.M117.779520 10.1016/j.cmet.2011.12.017 10.2147/DMSO.S195456
International Urology and Nephrology; Liu L, Lan S
Jan 3rd, 2021 - Diabetic nephropathy (DN) is a major complication of diabetic mellitus and usually leads to the end-stage renal disease. Inflammation-induced lipid disorders have been proposed to play an important role in the pathogenesis of DN. S100A16 is a nove...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745844
Renal Failure; Huang F, Wang L et. al.
Dec 14th, 2020 - This study explored whether lipid disorders or an elevated atherogenic index of plasma (AIP, a risk factor for cardiovascular diseases) could predict major kidney function decline. We conducted a retrospective 7-year cohort study of 3712 Chinese a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559587
International Journal of Environmental Research and Publi... Ratajczak J, Petriczko E
Sep 16th, 2020 - Children worldwide are increasingly becoming overweight and obese and developing related health problems, including hypertension, lipid disorders, abnormal glucose tolerance, type 2 diabetes, and secondary psychological disorders. The aim of the s...
https://doi.org/10.1073/pnas.2003976117
Proceedings of the National Academy of Sciences of the Un... Sinka ME, Pironon S et. al.
Sep 15th, 2020 - This study explored whether lipid disorders or an elevated atherogenic index of plasma (AIP, a risk factor for cardiovascular diseases) could predict major kidney function decline. We conducted a retrospective 7-year cohort study of 3712 Chinese a...
Guidelines 11 results
http://www.onlinejacc.org/content/early/2018/11/02/j.jacc.2018.11.003
Grundy, S.,et al
Nov 9th, 2018 - The recommendations listed in the present guideline are, whenever possible, evidence based. An initial extensive evidence review, which included literature derived from research involving human subjects, published in English, and indexed in MEDLIN.
https://www.ncbi.nlm.nih.gov/pubmed/28075093
American Family Physician;
Jan 11th, 2017 - Screening for Lipid Disorders in Children and Adolescents: Recommendation Statement.|2017||therapeutic use,diagnosis,therapy,diagnosis,drug therapy,
https://doi.org/10.1001/jama.2016.15450
JAMA , Bibbins-Domingo K et. al.
Nov 13th, 2016 - Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States, accounting for 1 of every 3 deaths among adults. To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid...
https://doi.org/10.1001/jama.2016.9852
JAMA , Bibbins-Domingo K et. al.
Aug 17th, 2016 - Elevations in levels of total, low-density lipoprotein, and non-high-density lipoprotein cholesterol; lower levels of high-density lipoprotein cholesterol; and, to a lesser extent, elevated triglyceride levels are associated with risk of cardiovas...
https://allmedx.com/USPSTFPDF/lipidscreening_ch-summary.pdf
Aug 2nd, 2016 - Figure. Screening for Lipid Disorders in Children and Adolescents: Clinical Summary Population Asymptomatic children and adolescents 20 years or younger Recommendation No recommendation. Grade: I (insufficient evidence) Ri...
Drugs 1 results see all →
Clinicaltrials.gov 561 results
https://doi.org/10.4158/CS-2020-0490
Endocrine Practice : Official Journal of the American Col... Handelsman Y, Jellinger PS et. al.
Jan 20th, 2021 - The treatment of lipid disorders begins with lifestyle therapy to improve nutrition, physical activity, weight, and other factors that affect lipids. Secondary causes of lipid disorders should be addressed, and pharmacologic therapy initiated base...
https://doi.org/10.1007/s11255-020-02731-4 10.3390/ijms20112850 10.1055/s-0042-110231 10.1016/S0140-6736(18)32279-7 10.1111/dom.14007 10.1111/jdi.12255 10.1007/s00592-015-0753-9 10.1152/ajprenal.00404.2009 10.1194/jlr.P040501 10.1016/j.ejphar.2012.02.027 10.1016/j.bbrc.2003.11.115 10.1210/en.2010-1059 10.3390/nu8010030 10.1074/jbc.M605798200 10.3168/jds.2015-9736 10.1158/0008-5472.CAN-13-0382-T 10.1002/kjm2.12226 10.1111/j.2040-1124.2011.00131.x 10.2147/IJNRD.S37893 10.5527/wjn.v3.i3.64 10.1016/j.biopha.2009.08.002 10.12659/MSM.917128 10.12659/MSM.915038 10.1016/j.intimp.2013.01.024 10.1016/0092-8674(94)90234-8 10.1002/jcb.28786 10.1155/2013/592576 10.1074/jbc.M117.779520 10.1016/j.cmet.2011.12.017 10.2147/DMSO.S195456
International Urology and Nephrology; Liu L, Lan S
Jan 3rd, 2021 - Diabetic nephropathy (DN) is a major complication of diabetic mellitus and usually leads to the end-stage renal disease. Inflammation-induced lipid disorders have been proposed to play an important role in the pathogenesis of DN. S100A16 is a nove...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745844
Renal Failure; Huang F, Wang L et. al.
Dec 14th, 2020 - This study explored whether lipid disorders or an elevated atherogenic index of plasma (AIP, a risk factor for cardiovascular diseases) could predict major kidney function decline. We conducted a retrospective 7-year cohort study of 3712 Chinese a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559587
International Journal of Environmental Research and Publi... Ratajczak J, Petriczko E
Sep 16th, 2020 - Children worldwide are increasingly becoming overweight and obese and developing related health problems, including hypertension, lipid disorders, abnormal glucose tolerance, type 2 diabetes, and secondary psychological disorders. The aim of the s...
https://doi.org/10.1073/pnas.2003976117
Proceedings of the National Academy of Sciences of the Un... Sinka ME, Pironon S et. al.
Sep 15th, 2020 - This study explored whether lipid disorders or an elevated atherogenic index of plasma (AIP, a risk factor for cardiovascular diseases) could predict major kidney function decline. We conducted a retrospective 7-year cohort study of 3712 Chinese a...
News 43 results
https://www.medscape.com/viewarticle/932275
Jun 12th, 2020 - Semglee, a long-acting human insulin analogue, has been approved for glycemic control in adults and children with type 1 diabetes and adults with type 2 diabetes, the Food and Drug Administration announced June 11. "Long-acting insulin products li...
https://www.mdedge.com/chestphysician/article/159901/acute-coronary-syndromes/200-cardiovascular-drugs-now-development
Richard Franki, MDedge News
Mar 2nd, 2018 - Heart failure, with 42 medicines currently in development, is the leading area for new treatments of cardiovascular disease, according to Pharmaceutical Research and Manufacturers of America. One of those 42 treatments is “a nonviral gene therapy.
https://www.mdedge.com/ccjm/article/152901/cardiology/it-time-abandon-fasting-routine-lipid-testing?channel=35
Zareen Farukhi, MD, Samia Mora, MD, MHS
Dec 1st, 2017 - Yes. The time has come to change the way we think about fasting before routine lipid testing.
https://www.medpagetoday.com/cardiology/prevention/68214
Sep 28th, 2017 - Common over-the-counter doses of biotin supplements -- popular for hair growth, lipid disorders, and other presumptive benefits -- interfere with assays for N-terminal pro-brain natriuretic peptide (NT-proBNP) and other common analytes in blood, r...
https://www.medpagetoday.com/cardiology/prevention/59656
Aug 11th, 2016 - The U.S. Preventive Services Task Force concluded that there was too little evidence to make any recommendations on universally screening children and adolescents for lipid disorders. But the panel's conclusion drew both praise and censure. "We di...